95 related articles for article (PubMed ID: 35418753)
1. Comments on "Emodin-Conjugated PEGylation of Fe
Wang X
Int J Nanomedicine; 2022; 17():1633-1634. PubMed ID: 35418753
[No Abstract] [Full Text] [Related]
2. Emodin-Conjugated PEGylation of Fe
Ren S; Song L; Tian Y; Zhu L; Guo K; Zhang H; Wang Z
Int J Nanomedicine; 2021; 16():7463-7478. PubMed ID: 34785894
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Emodin-Conjugated PEGylation of Fe
Int J Nanomedicine; 2022; 17():711-712. PubMed ID: 35210770
[TBL] [Abstract][Full Text] [Related]
4. Glypican-1-antibody-conjugated Gd-Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer.
Huang X; Fan C; Zhu H; Le W; Cui S; Chen X; Li W; Zhang F; Huang Y; Sh D; Cui Z; Shao C; Chen B
Int J Nanomedicine; 2018; 13():2585-2599. PubMed ID: 29750031
[TBL] [Abstract][Full Text] [Related]
5. Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent.
Kawano T; Murata M; Kang JH; Piao JS; Narahara S; Hyodo F; Hamano N; Guo J; Oguri S; Ohuchida K; Hashizume M
Biomaterials; 2018 Jan; 152():37-46. PubMed ID: 29107217
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
Zou J; Chen S; Li Y; Zeng L; Lian G; Li J; Chen S; Huang K; Chen Y
Nanoscale; 2020 Feb; 12(7):4473-4490. PubMed ID: 32031201
[TBL] [Abstract][Full Text] [Related]
7. Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles.
Zhu X; Lu N; Zhou Y; Xuan S; Zhang J; Giampieri F; Zhang Y; Yang F; Yu R; Battino M; Wang Z
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248076
[TBL] [Abstract][Full Text] [Related]
8. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
[TBL] [Abstract][Full Text] [Related]
9. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer.
Wang P; Yoo B; Sherman S; Mukherjee P; Ross A; Pantazopoulos P; Petkova V; Farrar C; Medarova Z; Moore A
Int J Cancer; 2016 Aug; 139(3):712-8. PubMed ID: 26996122
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-doped carbon quantum dots loaded magnetite nanoparticles as a bimodal nanoprobe for both fluorescence and magnetic resonance imaging.
Huang Y; Li L; Zhang D; Gan L; Zhao P; Zhang Y; Zhang Q; Hua M; Jia C
Magn Reson Imaging; 2020 May; 68():113-120. PubMed ID: 32032662
[TBL] [Abstract][Full Text] [Related]
11. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
Chen X; Zhou H; Li X; Duan N; Hu S; Liu Y; Yue Y; Song L; Zhang Y; Li D; Wang Z
EBioMedicine; 2018 Apr; 30():129-137. PubMed ID: 29574092
[TBL] [Abstract][Full Text] [Related]
12. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.
Chen L; Xie J; Wu H; Zang F; Ma M; Hua Z; Gu N; Zhang Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():339-346. PubMed ID: 29100127
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall Fe@Fe
Liu D; Li J; Wang C; An L; Lin J; Tian Q; Yang S
Nanomedicine; 2021 Feb; 32():102335. PubMed ID: 33220508
[TBL] [Abstract][Full Text] [Related]
14. Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Kim H; Folks KD; Guo L; Sellers JC; Fineberg NS; Stockard CR; Grizzle WE; Buchsbaum DJ; Morgan DE; George JF; Zinn KR
Mol Imaging; 2011 Jun; 10(3):153-67. PubMed ID: 21496446
[TBL] [Abstract][Full Text] [Related]
15. A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer.
Deng L; Ke X; He Z; Yang D; Gong H; Zhang Y; Jing X; Yao J; Chen J
Int J Nanomedicine; 2012; 7():5053-65. PubMed ID: 23028227
[TBL] [Abstract][Full Text] [Related]
16. Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy.
Yang H; He Y; Wang Y; Yang R; Wang N; Zhang LM; Gao M; Jiang X
Int J Nanomedicine; 2020; 15():3023-3038. PubMed ID: 32431499
[TBL] [Abstract][Full Text] [Related]
17. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
[TBL] [Abstract][Full Text] [Related]
18. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
[TBL] [Abstract][Full Text] [Related]
19. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
20. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
